As a cohort study, the results are associated with a difference in exposure to anticoagulation, but causation cannot be established. Furthermore, as a retrospective study, the effect of clinical judgment as a confounder cannot be measured.
Prior to these two papers, there was little literature that addressed restarting anticoagulation after GI bleeds. Physicians were left with anecdotal evidence and limited research to support their decisions regarding when to restart anticoagulation. As demonstrated by this research, restarting anticoagulation may have significant effects on morbidity and mortality.
Patients with GI bleeds who are also on anticoagulation for atrial fibrillation are not a rare occurrence. Reading this critical appraisal led to an informed discussion amongst the medical team and stressed the importance of using evidence to guide our clinical decision-making. Ultimately, we recommended to my patient's PCP that anticoagulation be restarted after one week.
